Modification of L-DOPA metabolism: Benefits and problems

被引：1

作者：

Brooks, David J. ^{[1
]}

机构：

[1] Imperial Coll Sch Med, Div Neurosci, Fac Med, London, England

来源：

EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 2008年 / 34卷 / 01期

关键词：

D O I：

10.1016/j.ejps.2008.02.016

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：S7 / S7

页数：1

相关论文

共 50 条

[41] L-DOPA FOR PARKINSONISM
REVENO, WS
BAUER, RB
ROSENBAUM, H
[J]. GERIATRICS, 1973, 28 (01) : 86 - 88
[42] TREATMENT OF PARKINSONS DISEASE WITH L-DOPA AND AN ASSOCIATION L-DOPA PLUS A DOPA DECARBOXYLASE INHIBITOR
FAZIO, C
BARBA, C
CASACCHIA, M
AGNOLI, A
RUGGIERI, S
VOLANTE, F
REITANO, M
[J]. ZEITSCHRIFT FUR NEUROLOGIE, 1972, 202 (04): : 347 - +
[43] EFFECT OF CHRONIC L-DOPA ADMINISTRATION ON CATECHOLAMINE METABOLISM IN RAT
LANCASTE.J
SAWYER, PR
SHEPHERD, DM
TURNBULL, MJ
[J]. BRITISH JOURNAL OF PHARMACOLOGY, 1973, 47 (04) : 838 - 842
[44] EFFECT OF L-DOPA TREATMENT ON INDOLE METABOLISM IN PARKINSONS DISEASE
BRUNE, GG
PFLUGHAU.KW
[J]. EXPERIENTIA, 1971, 27 (05): : 516 - &
[45] L-DOPA METABOLISM IN RAT EXOCRINE PANCREAS - BIOCHEMICAL STUDY
ALM, P
PETTERSON, GB
[J]. ACTA PHARMACEUTICA SUECICA, 1976, 13 (02): : 167 - 174
[46] Starting therapy in Parkinson's disease with L-dopa or agonists and the occurrence of late L-dopa motor problems in daily practice
Horstink, M. W. I. M.
Haaxma, C. A.
Borm, G. F.
Bloem, B. R.
[J]. MOVEMENT DISORDERS, 2007, 22 : S235 - S236
[47] L-DOPA AND OLIGOZOOSPERMIA
LAVIERI, JC
PIERINI, AA
[J]. ANDROLOGIA, 1978, 10 (01) : 74 - 79
[48] PRESCRIBING OF L-DOPA
SELBY, G
[J]. MEDICAL JOURNAL OF AUSTRALIA, 1971, 1 (14) : 770 - &
[49] PRESCRIBING OF L-DOPA
DINGLE, CJ
[J]. MEDICAL JOURNAL OF AUSTRALIA, 1971, 1 (09) : 498 - &
[50] L-DOPA AND PARKINSONISM
CALNE, DB
SANDLER, M
[J]. NATURE, 1970, 226 (5240) : 21 - +

← 1 2 3 4 5 →